Increased Lyme funding now included in House appropriations bill
From the Center for Lyme Action:
Two amendments to increase federal funding for Lyme disease were agreed to on the House floor to be included in the Fiscal Year 2022 House Labor HHS Appropriations bill, H.R. 4502.
The FY Labor HHS Appropriations bill, which will be voted on for final House passage later this week, is expected to be approved by the House. (July 29 update: The House today passed H.R. 4502. The issue awaits action from the Senate.)
This is a big victory because the House increased the CDC Lyme budget by 50% from $16M in FY21 to $24M in FY22, and NEW $5M funding for the LymeX Innovation Accelerator program was also approved.
Getting new line items in an appropriations bill is difficult and consequently, this is a very strong result.
Here are the two Amendments from the Floor debate:
- #50 Redirects $3 million from CDC-Wide Activities and Program Support to CDC’s Emerging Zoonotic and Infectious Diseases account for Lyme disease research and surveillance.
- #51 Decreases and then increases funding for the HHS Office of the Secretary by $5 million to express the intent that HHS use the $5 million for their recently announced LymeX Innovation Accelerator.
Thank you for all you are doing! Your emails and calls are working!
We’ll keep you posted on the next action.
Bonnie Crater, Jeff Crater, and Meredith Faucette
The Center for Lyme Action